| Literature DB >> 27042176 |
Thomas Chi1, Selma Masic1, Jianxing Li2, Manint Usawachintachit3.
Abstract
Purposes. To present our series of 38 prone percutaneous nephrolithotomy procedures performed with renal access and tract dilation purely under ultrasound guidance and describe the benefits and challenges accompanying this approach. Methods. Thirty-eight consecutive patients presenting for percutaneous nephrolithotomy for renal stone removal were included in this prospective cohort study. Ultrasonographic imaging in the prone position was used to obtain percutaneous renal access and guide tract dilation. Fluoroscopic screening was used only for nephrostomy tube placement. Preoperative, intraoperative, and postoperative procedural and patient data were collected for analysis. Results. Mean age of patients was 52.7 ± 17.2 years. Forty-five percent of patients were male with mean BMI of 26.1 ± 7.3 and mean stone size of 27.2 ± 17.6 millimeters. Renal puncture was performed successfully with ultrasonographic guidance in all cases with mean puncture time of 135.4 ± 132.5 seconds. Mean dilation time was 11.5 ± 3.8 min and mean stone fragmentation time was 37.5 ± 29.0 min. Mean total operative time was 129.3 ± 41.1. No patients experienced any significant immediate postoperative complication. All patients were rendered stone-free and no additional secondary procedures were required. Conclusions. Ultrasound guidance for renal access and tract dilation in prone percutaneous nephrolithotomy is a feasible and effective technique. It can be performed safely with significantly reduced fluoroscopic radiation exposure to the patient, surgeon, and intraoperative personnel.Entities:
Year: 2016 PMID: 27042176 PMCID: PMC4793096 DOI: 10.1155/2016/3840697
Source DB: PubMed Journal: Adv Urol ISSN: 1687-6369
Figure 1Establishing renal access using ultrasound guidance. (a) The operative surgeon (S) holds the ultrasound probe and the assistant (A) holds a syringe attached to ureteral catheter for normal saline infusion if needed. (b) Ultrasonographic image of the kidney along its longitudinal axis demonstrating the stone in the renal pelvis (white arrow) within a mildly hydronephrotic collecting system. (c) During the needle insertion, the operative surgeon (S) holds both the ultrasound probe and the needle to perform the puncture. For hand positioning, the nondominant hand holds the ultrasound probe while the dominant hand holds the needle. (d) The needle can be visualized (white arrow) entering the collecting system through upper pole calyx in this case.
Figure 2Introduction of working wire and dilators using ultrasound guidance. (a) A J-tip coaxial wire is inserted through the needle after its tip is confirmed in the collecting system. The operative surgeon (S) controls the needle with dominant hand and holds the ultrasound probe with the nondominant hand while the assistant (A) controls the wire. (b) Ultrasonographic image of the kidney demonstrating the wire (white arrow) in the collecting system after needle withdrawal. Its appearance is highly echogenic and prominent. (c) For fascial dilation, a 10-French fascial dilator is passed over the wire. Again, the operative surgeon (S) holds the ultrasound probe and controls the dilator while the assistant (A) controls the wire. (d) As the fascial dilator passes over the working wire, the wire is seen very clearly as an echogenic line (white arrow). The dilator obscures the view of the wire and this interface of the echogenic wire and the area where the wire disappears from view is the tip of the fascial dilator (yellow arrow).
Figure 3Tract dilation with high-pressure balloon under ultrasound guidance. (a) The deflated balloon dilator is inserted over a working wire and for this step, the operative surgeon (S) controls the ultrasound probe and distal end of the balloon while the assistant (A) controls the wire on the proximal end of the balloon dilator. (b) Ultrasonographic image of the kidney along its longitudinal axis demonstrates that the tip of the deflated balloon dilator (white arrow) is difficult to visualize and differentiate from the wire. (c) The sheath has been inserted over the inflated balloon dilator that is subsequently withdrawn. (d) The inflated balloon (white arrow) can be readily seen with ultrasound imaging.
Patient characteristics and perioperative parameters.
| Parameter | Ultrasound group | Fluoroscopy group |
|
|---|---|---|---|
| Preoperative characteristics | |||
| Mean (SD) age | 52.7 ± 17.2 | 52.9 ± 14.3 | 0.96 |
| Gender, | |||
| Male | 17 (44.7) | 19 (50.0) | 0.65 |
| Female | 21 (55.3) | 19 (50.0) | |
| Mean (SD) BMI (kg/m2) | 26.1 ± 7.3 | 30.3 ± 8.2 | 0.03 |
| Mean (SD) preoperative serum creatinine (mg/dL) | 0.92 ± 0.33 | 0.97 ± 0.37 | 0.51 |
| Mean (SD) preoperative hematocrit (%) | 39.0 ± 5.9 | 40.1 ± 4.9 | 0.38 |
| ASA physical status, | |||
| Class 1 | 7 (18.4) | 6 (15.8) | 0.36 |
| Class 2 | 17 (44.7) | 23 (60.5) | |
| Class 3 | 14 (36.9) | 9 (23.7) | |
| Stone laterality, | |||
| Right | 15 (39.5) | 16 (42.1) | 0.82 |
| Left | 23 (60.5) | 22 (57.9) | |
| Stone type and position, | |||
| Calyceal renal stone | 12 (31.6) | 9 (23.7) | 0.24 |
| Renal pelvic stone | 10 (26.3) | 14 (36.8) | |
| Staghorn stone | 6 (15.8) | 6 (15.8) | |
| Proximal ureteral stone | 3 (7.9) | 7 (18.4) | |
| Multiple stones | 7 (18.4) | 2 (5.3) | |
| Mean (SD) stone size (millimeters) | 27.2 ± 17.6 | 28.5 ± 14.5 | 0.72 |
| Degree of hydronephrosis, | |||
| None | 20 (52.6) | 15 (39.5) | 0.59 |
| Mild | 8 (21.1) | 13 (34.2) | |
| Moderate | 8 (21.1) | 8 (21.1) | |
| Severe | 2 (5.2) | 2 (5.2) | |
|
| |||
| Intraoperative measurements | |||
| Mean (SD) puncture time (seconds) | 135.4 ± 132.5 | NA | |
| Puncture location, | |||
| Upper calyx | 16 (42.1) | 3 (7.9) | 0.00 |
| Middle calyx | 7 (18.4) | 1 (2.6) | |
| Lower calyx | 15 (39.5) | 34 (89.5) | |
| Mean (SD) dilation time (minutes) | 11.5 ± 3.8 | NA | |
| Mean (SD) fragmentation time (minutes) | 37.5 ± 29.0 | NA | |
| Mean (SD) total operative time (minutes) | 129.3 ± 41.1 | 147.1 ± 52.1 | 0.11 |
| Mean (SD) radiation exposure dose (mGy) | 3.1 ± 3.2 | 47.5 ± 52.3 | 0.00 |
| Mean (SD) fluoroscopic screening time (seconds) | 17.7 ± 13.3 | 182.9 ± 119.0 | 0.00 |
|
| |||
| Postoperative outcomes | |||
| Mean (SD) postoperative serum creatinine (mg/dL) | 0.92 ± 0.37 | 1.01 ± 0.39 | 0.33 |
| Mean (SD) difference in preoperative and postoperative hematocrit (%) | 4.0 ± 5.6 | 2.6 ± 3.5 | 0.18 |
| Mean (SD) hospital stay (days) | 3.1 ± 1.4 | 2.9 ± 1.9 | 0.67 |
| Postoperative complication, | |||
| Grade 1 | 0 | 0 | 0.56 |
| Grade 2 | 1 (2.6) | 0 | |
| Grade 3 | 0 | 2 (5.3) | |
| Stone-free status, | |||
| Stone-free | 38 (100) | 34 (89.4) | 0.12 |
| Insignificant residual stone | 0 | 2 (5.3) | |
| Significant residual stone | 0 | 2 (5.3) | |